159 related articles for article (PubMed ID: 16104015)
21. The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites.
Strotmeier J; Gu S; Jutzi S; Mahrhold S; Zhou J; Pich A; Eichner T; Bigalke H; Rummel A; Jin R; Binz T
Mol Microbiol; 2011 Jul; 81(1):143-56. PubMed ID: 21542861
[TBL] [Abstract][Full Text] [Related]
22. Predictions of secondary structure and solvent accessibility of the light chain of the clostridial neurotoxins.
Lebeda FJ; Olson MA
J Nat Toxins; 1998 Oct; 7(3):227-38. PubMed ID: 9783261
[TBL] [Abstract][Full Text] [Related]
23. Structure and function of tetanus and botulinum neurotoxins.
Montecucco C; Schiavo G
Q Rev Biophys; 1995 Nov; 28(4):423-72. PubMed ID: 8771234
[TBL] [Abstract][Full Text] [Related]
24. Secondary structural predictions for the clostridial neurotoxins.
Lebeda FJ; Olson MA
Proteins; 1994 Dec; 20(4):293-300. PubMed ID: 7731948
[TBL] [Abstract][Full Text] [Related]
25. Crystallographic evidence for doxorubicin binding to the receptor-binding site in Clostridium botulinum neurotoxin B.
Eswaramoorthy S; Kumaran D; Swaminathan S
Acta Crystallogr D Biol Crystallogr; 2001 Nov; 57(Pt 11):1743-6. PubMed ID: 11679763
[TBL] [Abstract][Full Text] [Related]
26. The 25 kDa H
Deppe J; Weisemann J; Mahrhold S; Rummel A
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255952
[TBL] [Abstract][Full Text] [Related]
27. Interaction between a Novel Oligopeptide Fragment of the Human Neurotrophin Receptor TrkB Ectodomain D5 and the C-Terminal Fragment of Tetanus Neurotoxin.
Candalija A; Scior T; Rackwitz HR; Ruiz-Castelan JE; Martinez-Laguna Y; Aguilera J
Molecules; 2021 Jun; 26(13):. PubMed ID: 34208805
[TBL] [Abstract][Full Text] [Related]
28. Electrospray mass spectrometry of NeuAc oligomers associated with the C fragment of the tetanus toxin.
Conway MCP; Whittal RM; Baldwin MA; Burlingame AL; Balhorn R
J Am Soc Mass Spectrom; 2006 Jul; 17(7):967-976. PubMed ID: 16713287
[TBL] [Abstract][Full Text] [Related]
29. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
Kohda T; Ihara H; Seto Y; Tsutsuki H; Mukamoto M; Kozaki S
Microb Pathog; 2007; 42(2-3):72-9. PubMed ID: 17188834
[TBL] [Abstract][Full Text] [Related]
30. Tetanus and botulism neurotoxins: a novel group of zinc-endopeptidases.
Tonello F; Morante S; Rossetto O; Schiavo G; Montecucco C
Adv Exp Med Biol; 1996; 389():251-60. PubMed ID: 8861019
[TBL] [Abstract][Full Text] [Related]
31. Conformational analysis of GT1B ganglioside and its interaction with botulinum neurotoxin type B: a study by molecular modeling and molecular dynamics.
Venkateshwari S; Veluraja K
J Biomol Struct Dyn; 2012; 30(3):255-68. PubMed ID: 22746533
[TBL] [Abstract][Full Text] [Related]
32. Sequencing and phylogenetic analysis of neurotoxin gene from an environmental isolate of Clostridium sp.: comparison with other clostridial neurotoxins.
Dixit A; Alam SI; Singh L
Arch Toxicol; 2006 Jul; 80(7):399-404. PubMed ID: 16474961
[TBL] [Abstract][Full Text] [Related]
33. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
Rummel A; Mahrhold S; Bigalke H; Binz T
FEBS J; 2011 Dec; 278(23):4506-15. PubMed ID: 21624052
[TBL] [Abstract][Full Text] [Related]
34. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
Atassi MZ; Jankovic J; Steward LE; Aoki KR; Dolimbek BZ
Immunobiology; 2012 Jan; 217(1):17-27. PubMed ID: 21962573
[TBL] [Abstract][Full Text] [Related]
35. Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D.
Zhang Y; Gardberg AS; Edwards TE; Sankaran B; Robinson H; Varnum SM; Buchko GW
Biochimie; 2013 Jul; 95(7):1379-85. PubMed ID: 23523511
[TBL] [Abstract][Full Text] [Related]
36. Gangliosides as high affinity receptors for tetanus neurotoxin.
Chen C; Fu Z; Kim JJ; Barbieri JT; Baldwin MR
J Biol Chem; 2009 Sep; 284(39):26569-77. PubMed ID: 19602728
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel small molecules that bind to two different sites on the surface of tetanus toxin C fragment.
Cosman M; Lightstone FC; Krishnan VV; Zeller L; Prieto MC; Roe DC; Balhorn R
Chem Res Toxicol; 2002 Oct; 15(10):1218-28. PubMed ID: 12387617
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E.
Masuyer G; Davies JR; Stenmark P
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361086
[TBL] [Abstract][Full Text] [Related]
39. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
Jin R; Rummel A; Binz T; Brunger AT
Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin.
Nakamura T; Kotani M; Tonozuka T; Ide A; Oguma K; Nishikawa A
J Mol Biol; 2009 Jan; 385(4):1193-206. PubMed ID: 19071137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
